J. Taskinen

1.1k citations

28 papers · 816 indexed · h-index 14

Impact in

Pharmacology top 5%
- Pharmacogenetics and Drug Metabolism
Cardiology and Cardiovascular Medicine top 10%
- Heart Failure Treatment and Management
- Cardiac electrophysiology and arrhythmias
- Cardiac pacing and defibrillation studies

Papers in ⓘ

Filtration and Separation 1
Pharmacology 4
- Antibiotics Pharmacokinetics and Efficacy 3
- Drug-Induced Hepatotoxicity and Protection 3

Co-authors: Ismo Ulmanen (2 shared papers)Kenneth Lundström (2 shared papers)Carola Tilgmann (2 shared papers)Tom Wikberg (5 shared papers)Pekka Ottoila (5 shared papers)Nisse Kalkkinen (1 shared paper)Piero Pollesello (1 shared paper)Pekka T. Männistö (2 shared papers)
Journals: Drug Metabolism and Disposition (4 papers)Atherosclerosis (2 papers)Journal of Antimicrobial Chemotherapy (2 papers)The FASEB Journal (1 paper)European Journal of Clinical Pharmacology (1 paper)
Partner nations: Finland United Kingdom Germany

In The Last Decade

J. Taskinen

27 papers receiving 775 citations

Peers

Countries citing papers authored by J. Taskinen

Since Specialization

Citations

This map shows the geographic impact of J. Taskinen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Taskinen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Taskinen more than expected).

Fields of papers citing papers by J. Taskinen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Taskinen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Taskinen. The network helps show where J. Taskinen may publish in the future.

Co-authors

The 25 scholars most cited alongside J. Taskinen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with J. Taskinen Line = papers co-authored together J. Taskinen links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 28 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Binding of a new Ca2+ sensitizer, levosimendan, to recombinant human cardiac troponin C. A molecular modelling, fluorescence probe, and proton nuclear magnetic resonance study. Journal of Biological Chemistry ·Piero Pollesello, Martti Ovaska, Juha Kaivola, Carola Tilgmann, Kenneth Lundström, Nisse Kalkkinen, Ismo Ulmanen, Erkki Nissinen, J. Taskinen	1994	202
2	Characteristics of catechol O-methyltransferase (COMT) and properties of selective COMT inhibitors Birkhäuser Basel eBooks ·Pekka T. Männistö, Ismo Ulmanen, Kenneth Lundström, J. Taskinen, Jukka Tenhunen, Carola Tilgmann, Seppo Kaakkola	1992	144
3	Identification of major metabolites of the catechol-O-methyltransferase inhibitor entacapone in rats and humans. Drug Metabolism and Disposition ·Tom Wikberg, Annamari Vuorela, Pekka Ottoila, J. Taskinen	1993	77
4	The Specificity of Glucuronidation of Entacapone and Tolcapone by Recombinant Human Udp-Glucuronosyltransferases Drug Metabolism and Disposition ·Pia Lautala, Brian Ethell, J. Taskinen, Brian Burchell	2000	69
5	Pharmacokinetics and side-effects of clonidine European Journal of Clinical Pharmacology ·A. Ker�nen, S. Nyk�nen, J. Taskinen	1978	55
6	Coordination of inter-organelle communication and lipid fluxes by OSBP-related proteins Progress in Lipid Research ·Amita Arora, J. Taskinen, Vesa M. Olkkonen	2022	39
7	Trioxsalen bath plus UVA treatment of psoriasis. Plasma concentration of the drug and clinical results Acta Dermato Venereologica ·Salo Op, A Lassus, J. Taskinen	1981	35
8	Microplate screening assay to identify inhibitors of human catechol-O-methyltransferase Analytical Biochemistry ·Mika Kurkela, Antti Siiskonen, Moshe Finel, Päivi Tammela, J. Taskinen, Piia Vuorela	2004	21
9	Identification of major urinary metabolites of the catechol-O-methyltransferase inhibitor entacapone in the dog European Journal of Drug Metabolism and Pharmacokinetics ·Tom Wikberg, Pekka Ottoila, J. Taskinen	1993	18
10	ORP2, a cholesterol transporter, regulates angiogenic signaling in endothelial cells The FASEB Journal ·Annika Koponen, Guoping Pan, Annukka M. Kivelä, Arthur Ralko, J. Taskinen, Amita Arora, Riikka Kosonen, Otto K. Kari, Joseph Ndika, Elina Ikonen, Wonhwa Cho, Daoguang Yan, Vesa M. Olkkonen	2020	18
11	Identification of major metabolites of the catechol-O-methyltransferase-inhibitor nitecapone in human urine. Drug Metabolism and Disposition ·J. Taskinen, Tom Wikberg, Pekka Ottoila, L. C. Kanner, Timo Lotta, Aino Pippuri, Reijo Bäckström	1991	16
12	Insulin-inducible THRSP maintains mitochondrial function and regulates sphingolipid metabolism in human adipocytes Molecular Medicine ·Maria A. Ahonen, Marcus Höring, Van Dien Nguyen, S. U. Qadri, J. Taskinen, Meghana Nagaraj, Martin Wabitsch, Pamela Fischer‐Posovszky, You Zhou, Gerhard Liebisch, P.A. Nidhina Haridas, Hannele Yki‐Järvinen, Vesa M. Olkkonen	2022	14
13	Application of quantum chemical calculations to chemical ionisation mass spectrometry. Protonation and adduct formation in stereoisomeric 7-norbornenyl compounds International Journal of Mass Spectrometry and Ion Physics ·Jorma Jalonen, J. Taskinen, C. Glidewell	1983	14
14	ANGPTL3 deficiency alters the lipid profile and metabolism of cultured hepatocytes and human lipoproteins Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids ·Hanna Ruhanen, P.A. Nidhina Haridas, Ilenia Minicocci, J. Taskinen, Francesco Palmas, Alessia Di Costanzo, Laura D’Erasmo, Jari Metso, Jennimari Partanen, Jesmond Dalli, You Zhou, Marcello Arca, Matti Jauhiainen, Reijo Käkelä, Vesa M. Olkkonen	2020	13
15	Identification of major metabolites of the catechol-O-methyltransferase inhibitor nitecapone in the rat and dog. Drug Metabolism and Disposition ·Tom Wikberg, J. Taskinen	1993	13
16	Hydrolysis of 2'-esters of erythromycin Journal of Antimicrobial Chemotherapy ·J. Taskinen, Pekka Ottoila	1988	12
17	Protrudin regulates FAK activation, endothelial cell migration and angiogenesis Cellular and Molecular Life Sciences ·Amita Arora, Annukka M. Kivelä, Ling Wang, Rimante Minkeviciene, J. Taskinen, Birong Zhang, Annika Koponen, Jing Sun, Michiko Shirane, You Zhou, Pirta Hotulainen, Camilla Raiborg, Vesa M. Olkkonen	2022	12
18	Fate of single oral doses of erythromycin acistrate, erythromycin stearate and pelleted erythromycin base analysed by mass-spectrometry in plasma of healthy human volunteers Journal of Antimicrobial Chemotherapy ·Pekka T. Männistö, J. Taskinen, Pekka Ottoila, A. Solkinen, Arja Vuorela, Sirkka Nykänen	1988	11
19	Alterations of Cardiac Protein Kinases in Cyclic Nucleotide-Dependent Signaling Pathways in Human Ischemic Heart Failure Frontiers in Cardiovascular Medicine ·Chunguang Wang, J. Taskinen, Heli Segersvärd, Katariina Immonen, Riikka Kosonen, Johanna M. Tolva, Mikko I. Mäyränpää, Petri T. Kovanen, Vesa M. Olkkonen, Juha Sinisalo, Mika Laine, Ilkka Tikkanen, Päivi Lakkisto	2022	7
20	Determination of a catechol-O-methyltransferase inhibitor, nitecapone, in human plasma and urine by liquid chromatography Journal of Pharmaceutical and Biomedical Analysis ·Tom Wikberg, J. Taskinen	1991	6

About J. Taskinen

J. Taskinen is a scholar working on Filtration and Separation, Pharmacology, Cell Biology, Biochemistry and Cancer Research, having authored 28 papers that have together received 816 indexed citations. Recurring topics across this work include Cholesterol and Lipid Metabolism (4 papers), Analytical Chemistry and Chromatography (3 papers), Endoplasmic Reticulum Stress and Disease (3 papers), Antibiotics Pharmacokinetics and Efficacy (3 papers), Adipose Tissue and Metabolism (3 papers), Drug-Induced Hepatotoxicity and Protection (3 papers), Diet and metabolism studies (3 papers) and Cellular transport and secretion (3 papers). The work is most often cited by research in Pharmacology (126 citations), Cardiology and Cardiovascular Medicine (199 citations), Neurology (86 citations), Pharmacology (77 citations) and Anesthesiology and Pain Medicine (21 citations). J. Taskinen has collaborated with scholars based in Finland, United Kingdom and Germany. Frequent co-authors include Ismo Ulmanen, Kenneth Lundström, Carola Tilgmann, Tom Wikberg, Pekka Ottoila, Nisse Kalkkinen, Piero Pollesello, Pekka T. Männistö, Erkki Nissinen and Martti Ovaska. Their work appears in journals such as Drug Metabolism and Disposition, Atherosclerosis, Journal of Antimicrobial Chemotherapy, The FASEB Journal and European Journal of Clinical Pharmacology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact